Gene · 10225
Papers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,736
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PITPNC1 Suppress CD8+ T cell immune function and promote radioresistance in rectal cancer by modulating FASN/CD155. | J Transl Med | 2024 | 38291470 | PubTator, text mining | PubMed |
| Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected. | BMC Infect Dis | 2024 | 38287287 | PubTator, text mining | PubMed |
| Combining TIGIT blockade with IL-15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma. | Clin Transl Med | 2024 | 38279870 | PubTator, text mining | PubMed |
| Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity. | Immun Inflamm Dis | 2024 | 38270321 | PubTator, text mining | PubMed |
| Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer. | BMC Cancer | 2024 | 38263004 | PubTator, text mining | PubMed |
| The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia. | Cell Commun Signal | 2024 | 38254135 | PubTator, text mining | PubMed |
| Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer. | NPJ Precis Oncol | 2024 | 38245587 | PubTator, text mining | PubMed |
| Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors. | Cell Rep Med | 2024 | 38232701 | PubTator, text mining | PubMed |
| CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma. | PLoS One | 2024 | 38232115 | PubTator, text mining | PubMed |
| Targeting TIGIT for cancer immunotherapy: recent advances and future directions. | Biomark Res | 2024 | 38229100 | PubTator, text mining | PubMed |
| Graft CD8 T-cell-based risk system predicts survival in antithymocyte globulin-based myeloablative haploidentical peripheral blood stem cell transplantation. | Clin Transl Immunology | 2024 | 38223258 | PubTator, text mining | PubMed |
| The anoikis-related gene signature predicts survival and correlates with immune infiltration in osteosarcoma. | Aging (Albany NY) | 2024 | 38217543 | PubTator, text mining | PubMed |
| Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma. | Aging (Albany NY) | 2024 | 38206304 | PubTator, text mining | PubMed |
| WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy. | Eur J Med Res | 2024 | 38173030 | PubTator, text mining | PubMed |
| The chemokine receptor CXCR3 promotes CD8+ T cell-dependent lung pathology during influenza pathogenesis. | Sci Adv | 2024 | 38170765 | PubTator, text mining | PubMed |
| Function and mechanism of GBP1 in the development and progression of cervical cancer. | J Transl Med | 2024 | 38167153 | PubTator, text mining | PubMed |
| Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. | Clin Cancer Res | 2024 | 38153346 | PubTator, text mining | PubMed |
| Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma. | J Natl Cancer Inst | 2024 | 37944044 | PubTator, text mining | PubMed |
| Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists. | J Clin Invest | 2024 | 37906287 | PubTator, text mining | PubMed |
| Integrating bulk and single-cell data to predict the prognosis and identify the immune landscape in HNSCC. | J Cell Mol Med | 2024 | 37882107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10225/papers?page=7